GN 🧚‍♂️ Details performance! 🔬 I didn’t just “make” this painting ,I fought a whole boss battle with my eyes to finish it. #MultipleSclerosis (MS ) turns my vision into double, triple, and sometimes “WTF is happening” mode 😵‍💫 lol but honestly? It only made me tougher and way

When you are in ur 20’s and dx w/ #ms it’s overwhelming. You hear all the things that will eventually happen - it’s daunting- now in my 50’s it’s just exhausting! #MultipleSclerosis #MS #thisisMS #msresearch #mswarrior

Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5 https://t.co/Vdw6dtIaR5 #Biotech #Nasdaq #NYSE #QNTM #Health #MS #Multiplesclerosis #CTV #CTVNEWS #News #NationalNews #Canada #Spoofing

Everyone: "It’s the most wonderful time of the year!" 🎄 Me with MS: "…is it tho?" Download the https://t.co/EBTIk10Rxg app for free 👉📱 #MS #multiplesclerosis #MSAwareness #MSWarrior

Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC https://t.co/JOTyQwTcv8 $QNTM #Biotech #News #MS #Multiplesclerosis #Spoofing #Marketmanipulation

CTV News is running a 3-part Segment on Quantum BioPharma $QNTM Here’s the clip from Segment 1 Was a Canadian company’s multiple sclerosis research nearly derailed by ‘market manipulation’? https://t.co/dFp3mamDhW #News #QNTM #Biotech #Nasdaq #MS #Multiplesclerosis $QNTM

A collaborative @KBI_UHN & @uoftmedicine team has identified a biomarker linked to the inflammation that drives progressive #MultipleSclerosis. This discovery is a significant step toward more precise diagnosis & treatment. Read more🔗 https://t.co/xoK4mNNrX0

Neurology Podcast: Dr. Shuvro Roy and Dr. Rosa Cortese discuss new ways to improve #MultipleSclerosis and #MOGAD diagnosis, including how #AI and imaging could enhance accuracy and influence future care. Listen now: https://t.co/8aamoArhit #NeuroTwitter @RosaCortese5

🔊 Listen to @MSBase_Registry @UniMelb on the management of reactivation of #MultipleSclerosis during treatment with natalizumab. 📄And read the full manuscript ▶️ https://t.co/BDakFuhwx5

🧠 Tiny Gut Imposters Could Be Driving Multiple Sclerosis @NeuroscienceNew Study: @UniBasel_en #Neurology #MultipleSclerosis #Brain #MS #Microbiome #Neuroscience 👉 https://t.co/J9NVBE8jWg New research reveals that when #gut #bacteria closely resemble the #myelin sheath

Quiet progression, loud impact—Dr. Jiwon Oh shares how #BTKinhibitors are offering new hope in #MultipleSclerosis treatment.

The big question! 🤔 If you could explain just ONE MS symptom to a non-MSer to make them finally understand, what would it be and WHY? 👇 Download the https://t.co/EBTIk10Rxg app for free 👉📱 #MS #multiplesclerosis #MSAwareness #MSWarrior

Join us on January 22, 2026, for a captivating and inspiring program. Pavers Place - From Clinician to Patient: A Personal Journey from MS to Lifestyle Medicine https://t.co/u4MNzX3OD3 #pavingwellness #MultipleSclerosis #neurology #health #WellnessJourney

🎉 New Paper by Hemida et al. published in Multiple Sclerosis and Related Disorders (Q1 • IF: 2.9) indexed by Elsevier. I am so proud of my inspiring team for this hard work 👏🏻💪🏻 #Cardiology #Cardiovascular #Neurology #CVD #MultipleSclerosis #Q1Journal #Research

Published in @TheLancetNeuro: Newly released guidelines for diagnosing #MultipleSclerosis promise to make it possible to diagnose the disease, which affects ~1 million people in the U.S., earlier and earlier – even before symptoms appear: https://t.co/z31YauqbAF #Neurology

The @hospitaldelmar is leading a pioneering #clinicaltrial of spinal electrical stimulation in people with #MultipleSclerosis It will assess whether combining it with occupational therapy increases the ability to use the hands #Neurologia #Rehabilitació https://t.co/OoJZgWpUyT

In #pediatric patients with #multiplesclerosis, chronic lesion development begins early in the disease course, even with effective treatment. https://t.co/ITGNRomxxn

The Gommerman lab investigate an animal model of progressive #MultipleSclerosis & uncover a population of anti-CD20–resistant dural B cells that remain in the brain parenchyma at disease remission 📘 In Neuroscience 2025: https://t.co/a8B7pfNWwm

The FDA has rejected Sanofi's application seeking approval of tolebrutinib to treat certain forms of MS in its present form. https://t.co/E1OkisqOS6 #MultipleSclerosis #MSTreatment #MSResearch #MSNews